source
- Pfizer taps Blackstone for up to $1.5B to pave path to GLP-1's obesity launchPfizer has secured up to $1.5 billion from Blackstone Life Sciences to fund development of its monthly GLP-1 receptor agonist.
- HHS directs new funds, research for psychedelics workFollowing President Donald Trump’s executive order in the spring to make psychedelics research a priority, HHS on Thursday announced a flurry of new funding and studies into the field, with a speci…Endpoints · 1h ago↗ source
- ARPA-H bets $4.9 million on ibogaine for PTSD treatment in veteransThe U.S. department of health and human services announced a $4.9 million bet to advance the development of ibogaine for post-traumatic stress disorder (PTSD).